Vaccine For Omicron
-
{
- All
- News
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Vaccines Can Become Variant-Proof, Says New Study Amid Omicron Alert
Newer Covid variants - such as Delta and Omicron -carry mutations to the spike protein, which can make them less recognisable to the immune cells and antibodies stimulated by vaccination.
-
'Seeing Mild Symptoms, None Hospitalised': Doctor Behind 'Omicron' Alarm
Dr Angelique Coetzee said that we will know within two weeks if 'Omicron' is escaping vaccine immunity, whether it is causing reinfections, and how clinically bad it's going to be.
-
Omicron: Are New Vaccines Needed? What Vaccine-Makers Say
'Omicron', the new Covid variant first found in South Africa, has already caused global concern leading to countries shutting their borders, new travel guidelines, sell-offs in financial markets, and a bleak future for expected post-pandemic recovery
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Vaccines Can Become Variant-Proof, Says New Study Amid Omicron Alert
Newer Covid variants - such as Delta and Omicron -carry mutations to the spike protein, which can make them less recognisable to the immune cells and antibodies stimulated by vaccination.
-
'Seeing Mild Symptoms, None Hospitalised': Doctor Behind 'Omicron' Alarm
Dr Angelique Coetzee said that we will know within two weeks if 'Omicron' is escaping vaccine immunity, whether it is causing reinfections, and how clinically bad it's going to be.
-
Omicron: Are New Vaccines Needed? What Vaccine-Makers Say
'Omicron', the new Covid variant first found in South Africa, has already caused global concern leading to countries shutting their borders, new travel guidelines, sell-offs in financial markets, and a bleak future for expected post-pandemic recovery
